Antibiotice S.A. (BVB: ATB)

Antibiotice Revenue

Antibiotice had revenue of 172.67M RON in the quarter ending June 30, 2024, with 22.57% growth. This brings the company's revenue in the last twelve months to 650.70M, up 13.75% year-over-year. In the year 2023, Antibiotice had annual revenue of 615.29M with 21.84% growth.

• Revenue (ttm): 650.70M
• Revenue Growth: +13.75%
• P/S Ratio: 3.34
• Revenue / Employee: 481.29K
• Employees: 1,352
• Market Cap: 2.18B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	615.29M	110.29M	21.84%
Dec 31, 2022	505.00M	126.17M	33.31%
Dec 31, 2021	378.83M	31.60M	9.10%
Dec 31, 2020	347.22M	-47.92M	-12.13%
Dec 31, 2019	395.15M	26.45M	7.17%